Business
Oppenheimer, FDA haberleri üzerine Axsome Therapeutics hisse fiyat hedefini 220 dolara yükseltti
SOURCE:Investing Türkiye|BY:Investing.com
Failed to fetch content: Request failed with error code 403
Failed to fetch content: Request failed with error code 403